Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: Critical role of IFN-alpha

BMC Immunology

Volumn 9, Issue , 2008, Pages

  Satthaporn, Sukchai ^a   Aloysius, Mark M ^a   Robins, Richard A ^a   Verma, Chandan ^a   Chuthapisith, Suebwong ^a   Mckechnie, Alasdair J ^a   El Sheemy, Mohamad ^b,c   Vassanasiri, Wichai ^b   Valerio, David ^b   Clark, David ^b   Jibril, Jibril A ^b   Eremin, Oleg ^a,b  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

^b LINCOLN COUNTY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF LINCOLN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD86 ANTIGEN; DEXTRAN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 4; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA; CELL SURFACE RECEPTOR; CYTOKINE; LECTIN; MANNOSE BINDING LECTIN; MANNOSE RECEPTOR;

ANTIGEN EXPRESSION; ARTICLE; BLOOD; BREAST CANCER; CLONAL ANERGY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPH NODE; MIXED LYMPHOCYTE REACTION; MONOCYTE; PHAGOCYTOSIS; PINOCYTOSIS; BREAST TUMOR; CELL CULTURE; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE; METABOLISM;

ANTIGENS, CD86; BREAST NEOPLASMS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; DENDRITIC CELLS; HUMANS; IMMUNOPHENOTYPING; INTERFERON-ALPHA; LECTINS, C-TYPE; LYMPHOCYTES; MANNOSE-BINDING LECTINS; PINOCYTOSIS; RECEPTORS, CELL SURFACE;

EID: 47849113214     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-9-32     Document Type: Article

References (71)

1. Lenahan C Avigan D Dendritic cell defects in patients with cancer: mechanisms and significance.[comment] Breast Cancer Research 2006, 8(1):101. 1413989 16469120 10.1186/bcr1375
2. Pinzon-Charry A Maxwell T Lopez JA Dendritic cell dysfunction in cancer: a mechanism for immunosuppression Immunology & Cell Biology 2005, 83(5):451-461. 10.1111/j.1440-1711.2005.01371.x
3. Garcia-Lora A Algarra I Garrido F MHC class I antigens, immune surveillance, and tumor immune escape Journal of Cellular Physiology 2003, 195(3):346-355. 10.1002/jcp.10290 12704644
4. Gilboa E DC-based cancer vaccines Journal of Clinical Investigation 2007, 117(5):1195-1203. 1857263 17476349 10.1172/JCI31205
5. Kim R Emi M Tanabe K Arihiro K Immunobiology of the sentinel lymph node and its potential role for antitumour immunity Lancet Oncology 2006, 7(12):1006-1016. 10.1016/S1470-2045(06)70975-5 17138222
6. Austyn JM Dendritic cells Current Opinion in Hematology 1998, 5(1):3-15. 10.1097/00062752-199801000-00002 9515196
7. Hart DN Dendritic cells: Unique leukocyte populations which control the primary immune response Blood 1997, 90(9):3245-3287. 9345009
8. Satthaporn S Eremin O Dendritic cells (I): Biological functions Journal of the Royal College of Surgeons of Edinburgh 2001, 46(1):9-19. 11242749
9. S.Satthaporn AR M.El-Sheemy, D Valerio, J.A.Jibril, D.Clark, W.Vassanasiri, and O.Eremin Defective dendritic cell function and dysregulation of cytokines in women with breast cancer:fActors inducing tumour growth Proceedings of the American Association of Cancer Research 2001.
10. Radmayr C Bock G Hobisch A Klocker H Bartsch G Thurnher M Dendritic antigen-presenting cells from the peripheral blood of renal-cell-carcinoma patients International Journal of Cancer 1995, 63(5):627-632. 10.1002/ijc.2910630505
11. Ninomiya T Akbar SM Masumoto T Horiike N Onji M Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma Journal of Hepatology 1999, 31(2):323-331. 10.1016/S0168-8278(99)80231-1 10453947
12. Lespagnard L Gancberg D Rouas G Leclercq G de Saint-Aubain Somerhausen N Di Leo A Piccart M Verhest A Larsimont D Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: A study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome International Journal of Cancer 1999, 84(3):309-314. 10.1002/ (SICI)1097-0215(19990621)84:3<309::AID-IJC19>3.0.CO;2-3
13. Ishida T Oyama T Carbone DP Gabrilovich DI Defective function of Langerhans cells in tumor-bearing animals is the result of defective maturation from hemopoietic progenitors Journal of Immunology 1998, 161(9):4842-4851.
14. Chaux P Favre N Bonnotte B Moutet M Martin M Martin F Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression. A role in the immune tolerance to antigenic tumors Advances in Experimental Medicine & Biology 1997, 417:525-528.
15. Satthaporn S Robins A Vassanasiri W El-Sheemy M Jibril JA Clark D Valerio D Eremin O Dendritic cells are dysfunctional in patients with operable breast cancer Cancer Immunology, Immunotherapy 2004, 53(6):510-518. 10.1007/s00262-003-0485-5
16. Enk AH Dendritic cells in tolerance induction Immunology Letters 2005, 99(1):8-11. 10.1016/j.imlet.2005.01.011 15894104
17. Gabrilovich D Mechanisms and functional significance of tumour-induced dendritic-cell defects Nature Reviews Immunology 2004, 4(12):941-952. 10.1038/nri1498 15573129
18. Nestle FO Farkas A Conrad C Dendritic-cell-based therapeutic vaccination against cancer Current Opinion in Immunology 2005, 17(2):163-169. 10.1016/j.coi.2005.02.003 15766676
19. Aloysius MM RRA Eremin JM, Eremin O. Vaccination therapy in malignant disease Surgeon Journal of the Royal Colleges of Surgeons of Edinburgh & Ireland 2006, 4(5):309-320.
20. Caux C Dezutter-Dambuyant C Schmitt D Banchereau J GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells Nature 1992, 360(6401):258-261. 10.1038/360258a0 1279441
21. Jansen JH Wientjens GJ Fibbe WE Willemze R Kluin-Nelemans HC Inhibition of human macrophage colony formation by interleukin 4 Journal of Experimental Medicine 1989, 170(2):577-582. 2189394 2666563 10.1084/ jem.170.2.577
22. Romani N Gruner S Brang D Kampgen E Lenz A Trockenbacher B Konwalinka G Fritsch PO Steinman RM Schuler G Proliferating dendritic cell progenitors in human blood Journal of Experimental Medicine 1994, 180(1):83-93. 2191538 8006603 10.1084/jem.180.1.83
23. Dauer M Schad K Junkmann J Bauer C Herten J Kiefl R Schnurr M Endres S Eigler A IFN-alpha promotes definitive maturation of dendritic cells generated by short-term culture of monocytes with GM-CSF and IL-4 Journal of Leukocyte Biology 2006, 80(2):278-286. 10.1189/jlb.1005592 16769767
24. Radvanyi LG Banerjee A Weir M Messner H Low levels of interferon-alpha induce CD86 (B7.2) expression and accelerates dendritic cell maturation from human peripheral blood mononuclear cells Scandinavian Journal of Immunology 1999 50 5 499 509 10.1046/j.1365-3083.1999.00625.x 10564553
25. Wang C Al-Omar HM Radvanyi L Banerjee A Bouman D Squire J Messner HA Clonal heterogeneity of dendritic cells derived from patients with chronic myeloid leukemia and enhancement of their T-cells stimulatory activity by IFN-alpha Experimental Hematology 1999, 27(7):1176-1184. 10.1016/S0301-472X(99)00055-7 10390193
26. Bender A Sapp M Schuler G Steinman RM Bhardwaj N Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood Journal of Immunological Methods 1996, 196(2):121-135. 10.1016/0022-1759(96)00079-8 8841451
27. Reddy A Sapp M Feldman M Subklewe M Bhardwaj N A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cells Blood 1997, 90(9):3640-3646. 9345048
28. Nersting J Svenson M Andersen V Bendtzen K Maturation of human dendritic cells by monocyte-conditioned medium is dependent upon trace amounts of lipopolysaccharide inducing tumour necrosis factor alpha Immunology Letters 2003, 89(1):59-65. 10.1016/S0165-2478(03)00110-X 12946865
29. Belardelli F Gresser I The neglected role of type I interferon in the T-cell response: Implications for its clinical use Immunology Today 1996, 17(8):369-372. 10.1016/0167-5699(96)10027-X 8783497
30. Eloranta ML Sandberg K Ricciardi-Castagnoli P Lindahl M Alm GV Production of interferon-alpha/beta by murine dendritic cell lines stimulated by virus and bacteria Scandinavian Journal of Immunology 1997, 46(3):235-241. 10.1046/j.1365-3083.1997.d01-120.x 9315110
31. Ferbas JJ Toso JF Logar AJ Navratil JS Rinaldo CR Jr. CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection.[erratum appears in J Immunol 1994 Jul 15;153(2):910] Journal of Immunology 1994, 152(9):4649-4662.
32. Grage-Griebenow E Baran J Loppnow H Los M Ernst M Flad HD Pryjma J An Fc gamma receptor I (CD64)-negative subpopulation of human peripheral blood monocytes is resistant to killing by antigen-activated CD4-positive cytotoxic T cells European Journal of Immunology 1997, 27(9):2358-2365. 10.1002/eji.1830270934 9341781
33. Dowding C Gordon M Guo AP Maison D Osterholz J Siczkowski M Goldman J Potential mechanisms of action of interferon-alpha in CML Leukemia & Lymphoma 1993, 11(Suppl 1):185-191. 10.3109/10428199309047884 7504544
34. Wetzler M Kantarjian H Kurzrock R Talpaz M Interferon-alpha therapy for chronic myelogenous leukemia American Journal of Medicine 1995, 99(4):402-411. 10.1016/S0002-9343(99)80189-2 7573097
35. Luft T Pang KC Thomas E Hertzog P Hart DN Trapani J Cebon J Type I IFNs enhance the terminal differentiation of dendritic cells Journal of Immunology 1998, 161(4):1947-1953.
36. Banchereau J Briere F Caux C Davoust J Lebecque S Liu YJ Pulendran B Palucka K Immunobiology of dendritic cells Annual Review of Immunology 2000, 18:767-811. 10.1146/annurev.immunol.18.1.767 10837075
37. Svane IM Nikolajsen K Walter MR Buus S Gad M Claesson MH Pedersen AE Characterization of monocyte-derived dendritic cells maturated with IFN-alpha Scandinavian Journal of Immunology 2006, 63(3):217-222. 10.1111/j.1365-3083.2006.01728.x 16499575
38. Figdor CG de Vries IJ Lesterhuis WJ Melief CJ Dendritic cell immunotherapy: Mapping the way Nature Medicine 2004, 10(5):475-480. 10.1038/nm1039 15122249
39. Kalinski P Vieira PL Schuitemaker JH de Jong EC Kapsenberg ML Prostaglandin E(2) is a selective inducer of interleukin-12 p40 (IL-12p40) production and an inhibitor of bioactive IL-12p70 heterodimer Blood 2001, 97(11):3466-3469. 10.1182/blood.V97.11.3466 11369638
40. Langenkamp A Messi M Lanzavecchia A Sallusto F Kinetics of dendritic cell activation: Impact on priming of TH1, TH2 and nonpolarized T cells Nature Immunology 2000, 1(4):311-316. 10.1038/79758 11017102
41. Chakrabarti D Hultgren B Stewart TA IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2 Journal of Immunology 1996, 157(2):522-528.
42. Tatsumi T Takehara T Katayama K Mochizuki K Yamamoto M Kanto T Sasaki Y Kasahara A Hayashi N Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinoma Hepatology 1997, 25(5):1108-1114. 10.1002/hep.510250511 9141426
43. Caux C Vanbervliet B Massacrier C Azuma M Okumura K Lanier LL Banchereau J B70/B7-2 is identical to CD86 and is the major functional ligand for CD28 expressed on human dendritic cells Journal of Experimental Medicine 1994, 180(5):1841-1847. 2191743 7525840 10.1084/jem.180.5.1841
44. Larsen CP Ritchie SC Pearson TC Linsley PS Lowry RP Functional expression of the costimulatory molecule, B7/BB1, on murine dendritic cell populations Journal of Experimental Medicine 1992, 176(4):1215-1220. 2119403 1328465 10.1084/jem.176.4.1215
45. Pinchuk LM Klaus SJ Magaletti DM Pinchuk GV Norsen JP Clark EA Functional CD40 ligand expressed by human blood dendritic cells is up-regulated by CD40 ligation Journal of Immunology 1996, 157(10):4363-4370.
46. Seguin R Kasper LH Sensitized lymphocytes and CD40 ligation augment interleukin-12 production by human dendritic cells in response to Toxoplasma gondii Journal of Infectious Diseases 1999, 179(2):467-474. 10.1086/314601 9878033
47. Steinman RM The dendritic cell system and its role in immunogenicity Annual Review of Immunology 1991, 9:271-296. 10.1146/ annurev.iy.09.040191.001415 1910679
48. Young JW Koulova L Soergel SA Clark EA Steinman RM Dupont B The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. [erratum appears in J Clin Invest 1993 Apr;91(4):1853] Journal of Clinical Investigation 1992, 90(1):229-237. 443085 1378854 10.1172/JCI115840
49. Gruss HJ Herrmann F Gattei V Gloghini A Pinto A Carbone A CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues Leukemia & Lymphoma 1997, 24(5-6):393-422. 10.3109/10428199709055580 9086433
50. Zhou LJ Tedder TF Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily Journal of Immunology 1995, 154(8):3821-3835. 7706722
51. Dauer M Obermaier B Herten J Haerle C Pohl K Rothenfusser S Schnurr M Endres S Eigler A Mature dendritic cells derived from human monocytes within 48 hours: A novel strategy for dendritic cell differentiation from blood precursors.[see comment] Journal of Immunology 2003, 170(8):4069-4076.
52. Tamir A Jordan WJ Ritter M Habib N Lechler RI Foster GR Lombardi G Interferon-alpha2a is sufficient for promoting dendritic cell immunogenicity Clinical & Experimental Immunology 2005, 142(3):471-480. 16297159 1809533
53. Thurner B Roder C Dieckmann D Heuer M Kruse M Glaser A Keikavoussi P Kampgen E Bender A Schuler G Generation of large numbers of fully mature and stable dendritic cells from leukapheresis products for clinical application.[erratum appears in J Immunol Methods 1999 Apr 22;224(1-2):211] Journal of Immunological Methods 1999, 223(1):1-15. 10.1016/S0022-1759(98)00208-7 10037230
54. Zhou LJ TTF CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells Proc Natl Acad Sci USA 1996, 93(6):2588-2592. 39841 8637918 10.1073/pnas.93.6.2588
55. Pedersen AE Thorn M Gad M Walter MR Johnsen HE Gaarsdal E Nikolajsen K Buus S Claesson MH Svane IM Phenotypic and functional characterization of clinical grade dendritic cells generated from patients with advanced breast cancer for therapeutic vaccination Scandinavian Journal of Immunology 2005, 61(2):147-156. 10.1111/j.0300-9475.2005.01531.x 15683451
56. Dauer M Pohl K Obermaier B Meskendahl T Robe J Schnurr M Endres S Eigler A Interferon-alpha disables dendritic cell precursors: Dendritic cells derived from interferon-alpha-treated monocytes are defective in maturation and T-cell stimulation Immunology 2003, 110(1):38-47. 1783028 12941139 10.1046/j.1365-2567.2003.01702.x
57. Sallusto F Cella M Danieli C Lanzavecchia A Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products.[see comment] Journal of Experimental Medicine 1995, 182(2):389-400. 2192110 7629501 10.1084/ jem.182.2.389
58. Della Bella S Nicola S Riva A Biasin M Clerici M Villa ML Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon-alpha Journal of Leukocyte Biology 2004, 75(1):106-116. 10.1189/jlb.0403154 14525963
59. Kalinski P Schuitemaker JH Hilkens CM Wierenga EA Kapsenberg ML Final maturation of dendritic cells is associated with impaired responsiveness to IFN-gamma and to bacterial IL-12 inducers: Decreased ability of mature dendritic cells to produce IL-12 during the interaction with Th cells Journal of Immunology 1999, 162(6):3231-3236.
60. Klinke DJ 2nd The ratio of P40 monomer to dimer is an important determinant of IL-12 bioactivity Journal of Theoretical Biology 2006, 240(2):323-335. 10.1016/j.jtbi.2005.09.022 16448670
61. Reis e Sousa C Yap G Schulz O Rogers N Schito M Aliberti J Hieny S Sher A Paralysis of dendritic cell IL-12 production by microbial products prevents infection-induced immunopathology Immunity 1999, 11(5):637-647. 10.1016/S1074-7613(00)80138-7 10591188
62. Flores-Romo L Bjorck P Duvert V van Kooten C Saeland S Banchereau J CD40 ligation on human cord blood CD34+ hematopoietic progenitors induces their proliferation and differentiation into functional dendritic cells Journal of Experimental Medicine 1997, 185(2):341-349. 2196112 9016882 10.1084/jem.185.2.341
63. Sallusto F Lanzavecchia A Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha Journal of Experimental Medicine 1994, 179(4):1109-1118. 2191432 8145033 10.1084/jem.179.4.1109
64. Strobl H Riedl E Scheinecker C Bello-Fernandez C Pickl WF Rappersberger K Majdic O Knapp W TGF-beta 1 promotes in vitro development of dendritic cells from CD34+ hemopoietic progenitors Journal of Immunology 1996, 157(4):1499-1507. 8759731
65. Santiago-Schwarz F Laky K Carsons SE Stem cell factor enhances dendritic cell development Advances in Experimental Medicine & Biology 1995, 378:7-11.
66. Siena S Di Nicola M Bregni M Mortarini R Anichini A Lombardi L Ravagnani F Parmiani G Gianni AM Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy Experimental Hematology 1995, 23(14):1463-1471. 8542932
67. Young JW Szabolcs P Moore MA Identification of dendritic cell colony-forming units among normal human CD34+ bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha.[erratum appears in J Exp Med 1996 Mar 1;183(3):1283] Journal of Experimental Medicine 1995, 182(4):1111-1119. 2192302 7561684 10.1084/jem.182.4.1111
68. Caux C Vanbervliet B Massacrier C Durand I Banchereau J Interleukin-3 cooperates with tumor necrosis factor alpha for the development of human dendritic/Langerhans cells from cord blood CD34+ hematopoietic progenitor cells Blood 1996, 87(6):2376-2385. 8630401
69. Paquette RL Hsu NC Kiertscher SM Park AN Tran L Roth MD Glaspy JA Interferon-alpha and granulocyte-macrophage colony-stimulating factor differentiate peripheral blood monocytes into potent antigen-presenting cells Journal of Leukocyte Biology 1998, 64(3):358-367. 9738663
70. Ozzello L Habif DV De Rosa CM Cantell K Cellular events accompanying regression of skin recurrences of breast carcinomas treated with intralesional injections of natural interferons alpha and gamma Cancer Research 1992, 52(17):4571-4581. 1355007
71. McKechnie A RA Verma C, Hannoe J, Farzaneh F, Habib N, Eremin J, Eremin O Ex Vivo Generated Dendritic Cells Pulsed With Synthetic Human Telomerase Reverse Transcriptase (hTERT) Nonapeptides (p540 and p865) Stimulate Tetramer Positive T Cells In Vivo and In Vitro Using A Novel Combination Of Cytokines American Association of Cancer Research-Abstract 2004.